Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer

NCT00237575 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: gemcitabine
DRUG: cisplatin
DRUG: sargramostim
DRUG: filgrastim

Sponsor

University of Kentucky

Collaborators

[object Object]